Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
K. Krenn, S. Taghavi, W. Klepetko, S. Aharinejad (Vienna, Austria). Increased recipient VEGF serum level is a risk factor for severe reperfusion edema after lung transplantation. Eur Respir J 2005; 26: Suppl. 49, 4513

Member's Comments

No comment yet.

Related content which might interest you: Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 Lower level of keratinocyte growth factor contributes to severe lung injury in immunosuppressed rats model of pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 406s Year: 2005 Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts Source: Eur Respir J 2008; 31: 21-28 Year: 2008 Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure Source: Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020 Year: 2021 Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 779s Year: 2006 Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003 Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005 Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction Source: Eur Respir J, 56 (4) 2001968; 10.1183/13993003.01968-2020 Year: 2020 IL-8 in BAL-fluid of lung transplant patients: a possible predictive factor for upcoming acute rejection? Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003 Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Hepatocyte growth factor (HGF) in lung allografts Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Plasma levels of LL37 in patients with and at risk of acute lung injury Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Elevated factor FVIII:C levels in patients with pulmonary hypertension: a marked of endothelial dysfunction? Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 MMP-9 and TIMP-1 expression in acute lung injury rats with diabetes Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Oxidized-polymers of Z-AT are associated with exaggerated pulmonary inflammation post lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Tissue factor induced tumor vascular infarction in lung cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018